About The Alkaloid
The Alkaloid is a weekly intelligence briefing covering the science, culture, and business of cannabis, psychedelics, and plant medicine.
We publish every Tuesday. No noise. No agenda. Just sharp, honest coverage of one of the most consequential shifts in modern medicine and culture.
What We Cover
The plant medicine space sits at an unusual crossroads — where neuroscience meets policy, where ancient healing traditions meet venture capital, where criminal justice reform meets FDA approval timelines. Most publications cover one slice of that. We cover all of it.
Every issue includes:
- The Signal — one major story, examined in depth
- Quick Hits — the week's most important news, distilled
- Science Desk — research explained without the jargon
- Market Watch — where the money is moving and why
- The Last Word — a closing thought worth sitting with
Who It's For
Researchers and clinicians staying current on a fast-moving field. Investors tracking an emerging industry. Policy advocates following the legal landscape. Curious people who want to understand what's actually happening — not the hype, not the fear, just the signal.
Our Perspective
We believe plant medicine deserves rigorous, honest journalism. We follow the science wherever it leads. We pay attention to who benefits and who gets left behind. We take the history seriously — including the parts that are uncomfortable.
We don't have a political allegiance. We do have a point of view: that access to healing should not depend on your zip code or your income.
The Format
Free subscribers receive one issue per week — full access to The Dose, Quick Hits, and Science Desk.
Paid subscribers ($15/month or $120/year) receive the complete issue including Market Watch, The Last Word, and full archive access. Paid subscriptions keep this publication independent.
A Note on Independence
The Alkaloid accepts no funding from cannabis companies, psychedelic startups, or pharmaceutical interests. Sponsorships, when they occur, are clearly labeled and editorially separate from our coverage.
The Alkaloid publishes every Tuesday. Science, culture, and capital — one dose at a time.